GE research-led team treats diabetes using ultrasound
A GE Research-led team has demonstrated the ability to prevent or reverse diabetes in preclinical model systems using ultrasound-based bioelectronic medicine. The team's findings, published in Nature Biomedical Engineering, represent a significant milestone in this field and pave the way for future clinical translation.
SourceGeneral Electric (United States)·JournalNature Biomedical Engineering·TypeRandomized controlled/clinical trial·DateMar 31, 2022